176 related articles for article (PubMed ID: 17704752)
1. Radio-responsive TRAIL gene therapy for malignant gliomas.
Kyritsis AP; Rao JS; Puduvalli VK
Cancer Gene Ther; 2007 Dec; 14(12):1002. PubMed ID: 17704752
[No Abstract] [Full Text] [Related]
2. Radioresponsive tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy for malignant brain tumors.
Tsurushima H; Yuan X; Dillehay LE; Leong KW
Cancer Gene Ther; 2007 Aug; 14(8):706-16. PubMed ID: 17541421
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
4. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.
Corsten MF; Miranda R; Kasmieh R; Krichevsky AM; Weissleder R; Shah K
Cancer Res; 2007 Oct; 67(19):8994-9000. PubMed ID: 17908999
[TBL] [Abstract][Full Text] [Related]
6. Radiation-inducible caspase-8 gene therapy for malignant brain tumors.
Tsurushima H; Yuan X; Dillehay LE; Leong KW
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):517-25. PubMed ID: 18407431
[TBL] [Abstract][Full Text] [Related]
7. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice].
Sun W; Jiang Z; Xiang TX; Tao XH; Huang AL; Wang PL
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):841-5. PubMed ID: 19595126
[TBL] [Abstract][Full Text] [Related]
8. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration.
Lu W; Sun Q; Wan J; She Z; Jiang XG
Cancer Res; 2006 Dec; 66(24):11878-87. PubMed ID: 17178885
[TBL] [Abstract][Full Text] [Related]
9. Glioma gene therapy with soluble transforming growth factor-beta receptors II and III.
Naumann U; Maass P; Gleske AK; Aulwurm S; Weller M; Eisele G
Int J Oncol; 2008 Oct; 33(4):759-65. PubMed ID: 18813789
[TBL] [Abstract][Full Text] [Related]
10. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice.
Wang WB; Zhou YL; Heng DF; Miao CH; Cao YL
Breast Cancer Res Treat; 2008 Jul; 110(2):283-95. PubMed ID: 17899369
[TBL] [Abstract][Full Text] [Related]
11. [Gene therapy for brain tumors: induction of apoptosis and immunogenic modulation in glioma cells (series 5)].
Asai A
No Shinkei Geka; 1995 Jan; 23(1):7-15. PubMed ID: 7845524
[No Abstract] [Full Text] [Related]
12. 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas.
Mukai S; Kondo Y; Koga S; Komata T; Barna BP; Kondo S
Cancer Res; 2000 Aug; 60(16):4461-7. PubMed ID: 10969793
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of malignant brain tumors by using apoptosis].
Kuchino Y
No To Shinkei; 1995 Sep; 47(9):829-34. PubMed ID: 7546931
[No Abstract] [Full Text] [Related]
14. In vivo gene delivery by embryonic-stem-cell-derived astrocytes for malignant gliomas.
Uzzaman M; Keller G; Germano IM
Neuro Oncol; 2009 Apr; 11(2):102-8. PubMed ID: 18676359
[TBL] [Abstract][Full Text] [Related]
15. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
[TBL] [Abstract][Full Text] [Related]
16. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
Bian XW; Yang SX; Chen JH; Ping YF; Zhou XD; Wang QL; Jiang XF; Gong W; Xiao HL; Du LL; Chen ZQ; Zhao W; Shi JQ; Wang JM
Neurosurgery; 2007 Sep; 61(3):570-8; discussion 578-9. PubMed ID: 17881971
[TBL] [Abstract][Full Text] [Related]
17. The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat.
Liang B; He ML; Chan CY; Chen YC; Li XP; Li Y; Zheng D; Lin MC; Kung HF; Shuai XT; Peng Y
Biomaterials; 2009 Aug; 30(23-24):4014-20. PubMed ID: 19427690
[TBL] [Abstract][Full Text] [Related]
18. New innovations and developments for glioma treatment.
Croteau D; Mikkelsen T; Rempel SA; Bogler O; Rosenblum M
Clin Neurosurg; 2001; 48():60-81. PubMed ID: 11692657
[No Abstract] [Full Text] [Related]
19. [Biology and gene therapy of glioma].
Sanson M; Hoang-Xuan K
Rev Prat; 1996 Feb; 46(4):464-8. PubMed ID: 8729353
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of adenovirally expressed soluble TRAIL in human glioma organotypic slice culture and glioma xenografts.
Liu Y; Lang F; Xie X; Prabhu S; Xu J; Sampath D; Aldape K; Fuller G; Puduvalli VK
Cell Death Dis; 2011 Feb; 2(2):e121. PubMed ID: 21368892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]